Healthpeak Properties (NYSE:DOC) Given New $24.00 Price Target at Robert W. Baird

Key Points

• Robert W. Baird raised Healthpeak Properties’ price target from $21 to $24 while maintaining an “outperform” rating, implying roughly 16.3% upside from the stock’s $20.63 opening price.
• Healthpeak reported quarterly EPS of $0.08, exceeding the $0.03 consensus estimate, while revenue rose 11.1% year over year to $771.58 million. Analysts nevertheless maintain a consensus “Hold” rating with an average price target of $21.44.
• Institutional investors own 93.57% of Healthpeak’s shares, with several major firms—including Norges Bank, UBS Asset Management and Bank of New York Mellon—recently increasing or initiating positions.

Healthpeak Properties (NYSE:DOC - Get Free Report) had its price target hoisted by stock analysts at Robert W. Baird from $21.00 to $24.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The brokerage currently has an "outperform" rating on the real estate investment trust's stock. Robert W. Baird's target price would indicate a potential upside of 16.34% from the stock's current price.

A number of other brokerages have also issued reports on DOC. Weiss Ratings reissued a "hold (c)" rating on shares of Healthpeak Properties in a research note on Wednesday, August 5th. BMO Capital Markets upped their price objective on shares of Healthpeak Properties from $20.00 to $24.00 and gave the company an "outperform" rating in a research note on Monday, June 15th. Evercore cut shares of Healthpeak Properties from an "outperform" rating to an "in-line" rating and set a $21.00 target price on the stock. in a research report on Monday, May 11th. Citigroup upped their price target on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock a "neutral" rating in a research report on Tuesday. Finally, Wall Street Zen raised shares of Healthpeak Properties from a "sell" rating to a "hold" rating in a research note on Sunday, May 10th. Four investment analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the company's stock. Based on data from MarketBeat, Healthpeak Properties currently has an average rating of "Hold" and an average price target of $21.44.

Healthpeak Properties Trading Up 0.6%

Shares of DOC opened at $20.63 on Thursday. The stock has a fifty day moving average of $21.29 and a two-hundred day moving average of $18.87. The company has a debt-to-equity ratio of 1.06, a quick ratio of 3.02 and a current ratio of 3.02. The company has a market capitalization of $14.22 billion, a PE ratio of 58.94, a price-to-earnings-growth ratio of 3.15 and a beta of 1.01. Healthpeak Properties has a fifty-two week low of $15.70 and a fifty-two week high of $22.95.

Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.05. The business had revenue of $771.58 million for the quarter, compared to analysts' expectations of $725.64 million. Healthpeak Properties had a return on equity of 2.79% and a net margin of 8.24%.The business's revenue was up 11.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. As a group, analysts forecast that Healthpeak Properties will post 1.77 EPS for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Norges Bank purchased a new position in shares of Healthpeak Properties in the fourth quarter valued at $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Healthpeak Properties by 694.6% during the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust's stock worth $153,520,000 after buying an additional 7,007,777 shares during the period. Bank of New York Mellon Corp increased its stake in Healthpeak Properties by 60.3% during the 1st quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust's stock worth $253,949,000 after buying an additional 5,815,189 shares during the period. Fuller & Thaler Asset Management Inc. lifted its holdings in Healthpeak Properties by 19.2% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust's stock worth $476,744,000 after buying an additional 4,776,056 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA lifted its holdings in Healthpeak Properties by 214.0% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 4,230,551 shares of the real estate investment trust's stock worth $98,050,000 after buying an additional 2,883,382 shares in the last quarter. Institutional investors and hedge funds own 93.57% of the company's stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source